[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sugar Coated Tablets Market Data Survey Report 2013-2025

April 2019 | 62 pages | ID: GD8BF7287A8EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Sugar Coated Tablets are coated with a colored or an uncolored sugar layer. The coating is water soluble and quickly dissolves after swallowing. The sugar-coating protects the encapsulated drug from the environment and provides a barrier to objectionable tablet taste or odor.
The global Sugar Coated Tablets market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:

Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:
  • Pfizer
  • Novartis
  • Yangze River Pharmacelltcal
  • Bayer
  • XINHUA PHARMACEUTICAL
  • Harbin Pharmaceutical
  • Eisai
  • NCPC
  • GSK
  • Gebro
Major applications as follows:
  • Cardiovascular Diseases
  • Gastrointestinal Disease
  • Neurological Diseases
  • Immune Disease
  • Others
Major Type as follows:
  • Colored Sugar Coated Tablets
  • Colorless Sugar Coated Tablets
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Type
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Pfizer
  3.1.1 Company Information
  3.1.2 Product & Services
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.1.4 Recent Development
3.2 Novartis
  3.2.1 Company Information
  3.2.2 Product & Services
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.2.4 Recent Development
3.3 Yangze River Pharmacelltcal
  3.3.1 Company Information
  3.3.2 Product & Services
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.3.4 Recent Development
3.4 Bayer
  3.4.1 Company Information
  3.4.2 Product & Services
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.4.4 Recent Development
3.5 XINHUA PHARMACEUTICAL
  3.5.1 Company Information
  3.5.2 Product & Services
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.5.4 Recent Development
3.6 Harbin Pharmaceutical
  3.6.1 Company Information
  3.6.2 Product & Services
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.6.4 Recent Development
3.7 Eisai
  3.7.1 Company Information
  3.7.2 Product & Services
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.7.4 Recent Development
3.8 NCPC
  3.8.1 Company Information
  3.8.2 Product & Services
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.8.4 Recent Development
3.9 GSK
  3.9.1 Company Information
  3.9.2 Product & Services
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Gebro
  3.10.1 Company Information
  3.10.2 Product & Services
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Cardiovascular Diseases
  4.1.1 Overview
  4.1.2 Cardiovascular Diseases Market Size and Forecast
4.2 Gastrointestinal Disease
  4.2.1 Overview
  4.2.2 Gastrointestinal Disease Market Size and Forecast
4.3 Neurological Diseases
  4.3.1 Overview
  4.3.2 Neurological Diseases Market Size and Forecast
4.4 Immune Disease
  4.4.1 Overview
  4.4.2 Immune Disease Market Size and Forecast
4.5 Others
  4.5.1 Overview
  4.5.2 Others Market Size and Forecast

5 MARKET BY TYPE BY COLORED SUGAR COATED TABLETS

5.1 Colored Sugar Coated Tablets
  5.1.1 Overview
  5.1.2 Colored Sugar Coated Tablets Market Size and Forecast
5.2 Colorless Sugar Coated Tablets
  5.2.1 Overview
  5.2.2 Colorless Sugar Coated Tablets Market Size and Forecast

6 PRICE OVERVIEW

6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type

7 CONCLUSION

LIST OF TABLES

Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Yangze River Pharmacelltcal
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bayer
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of XINHUA PHARMACEUTICAL
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Harbin Pharmaceutical
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eisai
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of NCPC
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Gebro

LIST OF FIGURES

Fig Global Sugar Coated Tablets Market Size and CAGR 2013-2018 (Million USD)
Fig Global Sugar Coated Tablets Market Size and CAGR 2013-2018 (Volume)
Fig Global Sugar Coated Tablets Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Sugar Coated Tablets Market Forecast and CAGR 2019-2025 (Volume)
Fig Cardiovascular Diseases Market Size and CAGR 2013-2018 (Million USD)
Fig Cardiovascular Diseases Market Size and CAGR 2013-2018 (Volume)
Fig Cardiovascular Diseases Market Forecast and CAGR 2019-2025 (Million USD)
Fig Cardiovascular Diseases Market Forecast and CAGR 2019-2025 (Volume)
Fig Gastrointestinal Disease Market Size and CAGR 2013-2018 (Million USD)
Fig Gastrointestinal Disease Market Size and CAGR 2013-2018 (Volume)
Fig Gastrointestinal Disease Market Forecast and CAGR 2019-2025 (Million USD)
Fig Gastrointestinal Disease Market Forecast and CAGR 2019-2025 (Volume)
Fig Neurological Diseases Market Size and CAGR 2013-2018 (Million USD)
Fig Neurological Diseases Market Size and CAGR 2013-2018 (Volume)
Fig Neurological Diseases Market Forecast and CAGR 2019-2025 (Million USD)
Fig Neurological Diseases Market Forecast and CAGR 2019-2025 (Volume)
Fig Immune Disease Market Size and CAGR 2013-2018 (Million USD)
Fig Immune Disease Market Size and CAGR 2013-2018 (Volume)
Fig Immune Disease Market Forecast and CAGR 2019-2025 (Million USD)
Fig Immune Disease Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig Colored Sugar Coated Tablets Market Size and CAGR 2013-2018 (Million USD)
Fig Colored Sugar Coated Tablets Market Size and CAGR 2013-2018 (Volume)
Fig Colored Sugar Coated Tablets Market Forecast and CAGR 2019-2025 (Million USD)
Fig Colored Sugar Coated Tablets Market Forecast and CAGR 2019-2025 (Volume)
Fig Colorless Sugar Coated Tablets Market Size and CAGR 2013-2018 (Million USD)
Fig Colorless Sugar Coated Tablets Market Size and CAGR 2013-2018 (Volume)
Fig Colorless Sugar Coated Tablets Market Forecast and CAGR 2019-2025 (Million USD)
Fig Colorless Sugar Coated Tablets Market Forecast and CAGR 2019-2025 (Volume)


More Publications